COPLAND ROAD CAPITAL NEW
Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics … Read more
COPLAND ROAD CAPITAL NEW (A2P) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, COPLAND ROAD CAPITAL NEW (A2P) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
COPLAND ROAD CAPITAL NEW - Net Assets Trend (None–None)
This chart illustrates how COPLAND ROAD CAPITAL NEW's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for COPLAND ROAD CAPITAL NEW (None–None)
The table below shows the annual net assets of COPLAND ROAD CAPITAL NEW from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to COPLAND ROAD CAPITAL NEW's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
COPLAND ROAD CAPITAL NEW Competitors by Market Cap
The table below lists competitors of COPLAND ROAD CAPITAL NEW ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
So-Young International Inc
NASDAQ:SY
|
$135.27 Million |
|
Nanhua Instruments Co Ltd
SHE:300417
|
$135.28 Million |
|
Firm Capital Property Trust
PINK:FRMUF
|
$135.29 Million |
|
Rajesh Exports Limited
NSE:RAJESHEXPO
|
$135.30 Million |
|
Zuming Bean Products Co Ltd
SHE:003030
|
$135.19 Million |
|
Seoul Broadcasting System
KO:034120
|
$135.19 Million |
|
Kaldalón hf.
IC:KALD
|
$135.16 Million |
|
Patrimoine et Commerce SA
PA:PAT
|
$135.14 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in COPLAND ROAD CAPITAL NEW's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares COPLAND ROAD CAPITAL NEW's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently COPLAND ROAD CAPITAL NEW utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares COPLAND ROAD CAPITAL NEW's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| COPLAND ROAD CAPITAL NEW (A2P) | €- | N/A | N/A | $135.22 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |